search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
PEOPLE ▶▶▶


Dr. Eckel With immediate effect, Ar- gentinian agriculture and animal health expert Gui- do Grassi, aged 46, takes over the position of Chief Operations Officer at Ger- man animal nutrition com- pany Dr. Eckel. In the past he held positions with Bayer and Elanco.


Tyson Foods For personal reasons, Tyson Foods’ president and CEO Dean Banks has left the US meatpacker. He had only been CEO since October 2020. He was succeeded by COO Donnie King, effective immediately.


DLG On 1 May 2021, Tobias Eichberg (pictured) took over as managing director of the exhibitions depart- ment of the German Agri- cultural Society (DLG). DLG is organiser of the EuroTier shows. He succeeds Peter Grothues, who will be retiring on 31 July.


NPPC CEO Neil Dierks of the US National Pork Producers Coun- cil (NPPC) will retire at the end of 2021. He has been with NPPC for 31 years, the last 20 years of which he was CEO. The search for a new CEO has begun.


Roslin Technologies UK-based Roslin Technologies has named Dutchman Ernst van Orsouw as Chief Executive Officer. He will drive the strategic agenda as the company moves from focusing on technological innovations to deploying those advances through sales and partnership agreements.


Novus Alfred Zimmerman (pic- tured) will join animal nutri- tion company Novus’ execu- tive leadership team as chief innovation officer, identify- ing ways to grow the spe- cialty product line. In addi- tion, Uwe Ranft was named chief strategic marketing and technology officer, strengthening the company’s strategic marketing and tech- nical service teams and overseeing the strategic accounts.


32 Webinar on global vs local sourcing


Should feed producers source their raw materials globally or locally? A recent webinar that touched on this topic is now available for watching on demand. The question was addressed in the third and last webinar from All About Feed in cooperation with GMP+ Inter- national. It was held on Wednesday 12 May. The three webinars were held in preparation for the Global Feed Safe- ty Summit, taking place 6–8 April 2022 in Berlin, Germany. Introducing the theme was Michael Magdovitz (middle in the picture) from Rabobank. He looked at the sourc- ing of raw materials from a financial an- gle. Low raw material stocks are lead- ing to high commodity prices. This is caused, he said, by low numbers of


plantings due to Covid-19 in combina- tion with a feed surge in China. The next speaker was Mark McHugh (fourth from the left), from AB Agri. He zoomed in on the “why” of global sourcing of raw materials, as it plays a crucial role in meeting demand for nu- tritious, cost-effective food. The third speaker was Susanne From- wald (right) from Donau Soja. She said that increased soy production in Euro- pe is very possible, and has both eco- logical and economic effects. Closing off the webinar, Johan den Hartog (left), managing director of GMP+ International, wrapped up the theme and invited the audience to save the date for next year’s Global Feed Safety Summit.


Better cell line for PRRS vaccine


American research has found a new cell line that could enhance the develop- ment of autogenous vaccinations for the Porcine Reproductive and Respira- tory Syndrome (PRRS) virus. That result has been shared by researchers from Iowa State University in a study that ap- peared recently in the peer-reviewed Journal of Clinical Microbiology. Because PRRS virus has high antigenic and genetic diversity, commercial vac- cinations do not necessarily provide ef-


▶ PIG PROGRESS | Volume 37, No. 5/6, 2021


fective protection. Farmers of swine herds facing the virus use autogenous vaccinations instead, which are devel- oped from on-farm samples. To pro- duce such vaccines the virus must be isolated, and this can be a difficult pro- cess. The research has discovered that a new cell line – ZMAC taken from pigs’ lungs – may be a better alternative compared to the MARC-145 line from an African monkey kidney that is currently in use.


PHOTO: NOVUS


PHOTO: DLG


PHOTO: DR ECKEL


PHOTO: COMPANY WEBCAST


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36